clindamycin and mitomycin

clindamycin has been researched along with mitomycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cheng, YW; Kang, JJ; Li, CH; Tzeng, SL1

Reviews

1 review(s) available for clindamycin and mitomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for clindamycin and mitomycin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway.
    The Journal of biological chemistry, 2005, Jul-15, Volume: 280, Issue:28

    Topics: Anti-Bacterial Agents; Apoptosis; beta-Galactosidase; Biomarkers; Blotting, Western; Caspase 3; Caspases; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cellular Senescence; Chloramphenicol; Clindamycin; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 1; Cytochromes c; Cytoplasm; DNA; DNA Damage; DNA, Complementary; Down-Regulation; Doxycycline; Enzyme Activation; Enzyme Inhibitors; G1 Phase; Genes, Reporter; Humans; Membrane Potentials; Membrane Proteins; Microscopy, Fluorescence; Minocycline; Mitochondria; Mitomycin; Oligonucleotides, Antisense; Plasmids; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein Biosynthesis; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes; RNA; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Suppressor Protein p53

2005